STOCKHOLM, Feb. 23, 2022 /PRNewswire/ — “During the fourth quarter of 2021, order intake rose 44 percent and net sales 18 percent. Operating loss amounted to SEK -17 M (-15),” says Johan Löf, CEO of RaySearch
FOURTH QUARTER (OCTOBER – DECEMBER 2021)
TWELVE MONTHS (JANUARY – DECEMBER 2021)
SIGNIFICANT EVENTS DURING THE FOURTH QUARTER
The COVID-19 pandemic
NO SIGNIFICANT EVENTS AFTER THE END OF THE REPORTING PERIOD
WEBCAST
CEO Johan Löf and CFO Torbjörn Wingårdh will present RaySearch’s year-end report for January-December 2021 at a webcast to be held in English on Wednesday, February 23, 2022 between 10:00-10:30 p.m. CET.
For login details to the webcast, please register on: https://raysearchlabs.creo.se/220223
FOR FURTHER INFORMATION PLEASE CONTACT:
Johan Löf, CEO, +46 (0)8 510 530 00, https://raysearchlabs.creo.se/220223
Torbjörn Wingårdh, CFO, +46 (0)70 00 394 76, torbjorn.wingardh@raysearchlabs.com
The information contained in this interim report is such that RaySearch Laboratories AB (publ) is obliged to disclose under the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication on February 23, 2022 at 7:45 a.m. CET.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
* Subject to regulatory clearance in some markets.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/raysearch-laboratories/r/year-end-report-2021,c3512387
The following files are available for download:
RaySearch year-end report 2021 |
View original content:https://www.prnewswire.com/news-releases/raysearch-laboratories–year-end-report-2021-301488255.html
SOURCE RaySearch Laboratories
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…
3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…
The new app allows users to browse services, book IV therapy, manage appointments, purchase packages,…
PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform…
NEW YORK, Nov. 22, 2024 /PRNewswire/ -- Report with market evolution powered by AI -…
To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added…